← Back to headlines
FDA Accepts Inhibrx BLA for Ozekibart
The U.S. Food and Drug Administration (FDA) has accepted Inhibrx's Biologics License Application (BLA) for ozekibart.
15 Jun, 14:34 — 15 Jun, 14:34
Sources
Showing 1 of 1 sources
The U.S. Food and Drug Administration (FDA) has accepted Inhibrx's Biologics License Application (BLA) for ozekibart.
